Table 2.
Laboratory findings at baseline and after TACE
| Laboratory findings | Baseline, Mean ± SD | Post-TACE, Mean ± SD | p-value |
|---|---|---|---|
| Total bilirubin (mg/dL) | 1.03 ± 0.61 | 1.17 ± 0.86 | 0.027* |
| AST (U/L) | 77.20 ± 51.65 | 73.69 ± 57.05 | 0.59 |
| ALT (U/L) | 56.21 ± 38.35 | 52.48 ± 43.95 | 0.300 |
| Albumin (g/dL) | 3.50 ± 0.57 | 3.20 ± 0.56 | <0.001* |
| INR | 1.16 ± 0.13 | 1.20 ± 0.13 | <0.001* |
| Platelet (× 103/µL) | 167.46 ± 107.53 | 169.58 ± 116.82 | 0.62 |
| Creatinine (mg/dL) | 0.89 ± 0.36 | 0.88 ± 0.68 | 0.93 |
| AFP (ng/mL) | 3460.38 ± 14382.67 | 2449.96 ± 8.177.59 | 0.85 |
AFP Alpha fetoprotein, ALT Alanine aminotransferase, AST Aspartate aminotransferase, INR International normalized ratio, mg/dL Milligram per deciliter; ng/mL, Nanogram per milliliter; SD Standard deviation, TACE Trans-arterial chemoembolization, U/L Units per liter, µL Microliter
*p-value ≤ 0.05